Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tamar Kikvidze"'
Autor:
Maia Butsashvili, Tinatin Abzianidze, George Kamkamidze, Lasha Gulbiani, Lia Gvinjilia, Tinatin Kuchuloria, Irina Tskhomelidze, Maka Gogia, Maia Tsereteli, Veronique Miollany, Tamar Kikvidze, Shaun Shadaker, Muazzam Nasrullah, Francisco Averhoff
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 17, Iss 1, Pp 1-6 (2022)
Abstract Background People who inject drugs (PWID) in Georgia have a high prevalence of hepatitis C virus antibody (anti-HCV). Access to care among PWID could be prioritized to meet the country’s hepatitis C elimination goals. This study assesses b
Externí odkaz:
https://doaj.org/article/39abec1820434547a830ec50f7ab5934
Autor:
George Kamkamidze, Veronique Miollany, L Gulbiani, Irina Tskhomelidze, Tamar Kikvidze, Muazzam Nasrullah, Maia Tsereteli, Tinatin Abzianidze, Francisco Averhoff, Shaun Shadaker, Maia Butsashvili, Lia Gvinjilia, Maka Gogia, Tinatin Kuchuloria
Background: People who inject drugs (PWID) in Georgia have a high prevalence of hepatitis C virus antibody (anti-HCV). Access to care among PWID could be prioritized to meet the country’s hepatitis C elimination goals. This study assesses barriers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb6c5a229417dd6e2fdb5f2e8882edb7
https://doi.org/10.21203/rs.3.rs-151914/v2
https://doi.org/10.21203/rs.3.rs-151914/v2
Autor:
Tamar Kikvidze, Konstantine Labartkava, Niklas Luhmann, George Kamkamidze, Aurélie Etienne, Julie Bouscaillou, Elisabeth Avril, David Kharshiladze, Diane Le Pluart, Ina Inaridze, Maia Butsashvili, Ana Gamezardashvili
Publikováno v:
International Journal of Drug Policy. 62:104-111
Background People who inject drugs (PWID) are often excluded from HCV treatment programs due to concerns about their ability to adhere to care. Georgia has a high prevalence of HCV infection (5.4% of chronic cases in general population) with an epide
Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia
Autor:
Konstantine Labartkava, Elisabeth Avril, Maia Butsashvili, Niklas Luhmann, Tamar Kikvidze, David Kharshiladze, Julie Bouscaillou, Aurélie Etienne, Diane Le Pluart, Ina Inaridze, Ana Gamezardashvili
Publikováno v:
International Journal of Drug Policy. 52:16-19
Backgrounds Georgia faces high HCV rates (5.4% of chronic cases in general population) with an epidemic concentrated among people who inject drugs (PWID). A National HCV Elimination Program (NHCEP), was launched in April 2015, aiming to eliminate HCV
Autor:
Konstantine Labartkava, Elisabeth Avril, Maia Butsashvili, Tamar Kikvidze, Julie Bouscaillou, Niklas Luhmann, Ana Gamezardashvili, George Kamkamidze, Ina Inaridze, Aurélie Etienne
Publikováno v:
Journal of Hepatology. 66:S409
Publikováno v:
Journal of Liver.
Hepatitis B Virus (HBV) infection is a global health problem that is endemic in many parts of the world. 90-95% of the infected adults can clear the virus. Host genetic factors play a major role in determining the outcome of HBV infection. This study